Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,578.78
(
-0.24%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: north40000 post# 257350

Monday, 03/07/2016 5:51:24 PM

Monday, March 07, 2016 5:51:24 PM

Post# of 347009
This is a good assignment to map out all those in NCCN vs all those taking part of ORIEN, then seeing where we overlap and I would guess that the blood bank/tissue bank..etc... out of ORIEN would make all this data accessible to NCCN and flipping PS will be everywhere

I guess Peregrine can't predict exactly when certain news comes out of these networks but Dr. Raymond Birge (part of ORIEN and NCCN) will certainly be the tip of a very big iceberg ...

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote